BRIEF published on 11/13/2024 at 18:05, 1 year ago Innelec: Turnover down in the first half of 2024/25 Consolidation Perspectives INNELEC Turnover Video Games
BRIEF published on 09/25/2024 at 17:50, 1 year 2 months ago Innelec: Report of the General Meeting of September 18, 2024 General Meeting Resolutions Adopted Approved Accounts Earmarked Profit No Dividends
BRIEF published on 08/13/2024 at 17:50, 1 year 3 months ago INNELEC turnover to decline for the first quarter of 2024/25 INNELEC Turnover Video Games Savings Plan Quarter 2024/25
BRIEF published on 07/31/2024 at 17:50, 1 year 4 months ago Innelec: Availability of the 2023-24 annual financial report Investors AMF Financial Report INNELEC 2023-2024
BRIEF published on 07/02/2024 at 17:53, 1 year 5 months ago Half-yearly H1 review of ENTECH's liquidity contract with Portzamparc Entech Liquidity Contract PORTZAMPARC BNP Paribas Group
BRIEF published on 06/12/2024 at 17:50, 1 year 5 months ago INNELEC MULTIMEDIA: Annual results 2023/24 INNELEC MULTIMEDIA Growth Annual Results Turnover Video Games
Published on 12/05/2025 at 02:35, 2 hours 45 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 20 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 15 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 20 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 49 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 29 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 54 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 5 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 9 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 35 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 19 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
